Modified BEAM Regimen for T Cell Lymphoma Underwent ASCT
Status:
Not yet recruiting
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
A multicenter randomized study on the efficacy and safety of mitoxantrone hydrochloride
liposome injection combined with carmustine, etoposide, and cytarabine (modified BEAM
protocol) in the pretreatment of T-cell lymphoma underwent autologous stem cell
transplantation
Phase:
N/A
Details
Lead Sponsor:
First Affiliated Hospital Xi'an Jiaotong University